Oscar Health (NYSE:OSCR) Price Target Increased to $24.00 by Analysts at Wells Fargo & Company

Oscar Health (NYSE:OSCR) had its target price boosted by equities research analysts at Wells Fargo & Company from $20.00 to $24.00 in a report issued on Thursday, Benzinga reports. The firm presently has an “overweight” rating on the stock. Wells Fargo & Company‘s target price indicates a potential upside of 11.06% from the company’s previous close.

A number of other analysts also recently commented on OSCR. Raymond James began coverage on Oscar Health in a research note on Friday, March 22nd. They issued an “outperform” rating and a $20.00 price objective on the stock. The Goldman Sachs Group boosted their target price on Oscar Health from $16.00 to $21.00 and gave the company a “neutral” rating in a research note on Thursday. Finally, TheStreet upgraded Oscar Health from a “d” rating to a “c-” rating in a research note on Wednesday, February 21st. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Oscar Health currently has an average rating of “Moderate Buy” and a consensus price target of $15.00.

Oscar Health Trading Up 4.2 %

Shares of NYSE OSCR traded up $0.87 during trading on Thursday, hitting $21.61. 1,869,778 shares of the company traded hands, compared to its average volume of 3,279,387. The firm has a market capitalization of $4.96 billion, a P/E ratio of -17.87 and a beta of 1.66. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.37. The company has a 50-day moving average price of $15.50 and a 200-day moving average price of $12.02. Oscar Health has a 1 year low of $4.72 and a 1 year high of $21.62.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Tuesday, May 7th. The company reported $0.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.34. Oscar Health had a negative return on equity of 29.99% and a negative net margin of 4.62%. The company had revenue of $2.14 billion for the quarter, compared to the consensus estimate of $1.99 billion. During the same period in the previous year, the business earned ($0.18) EPS. Oscar Health’s revenue for the quarter was up 45.8% compared to the same quarter last year. On average, equities analysts predict that Oscar Health will post -0.23 EPS for the current year.

Hedge Funds Weigh In On Oscar Health

Several large investors have recently added to or reduced their stakes in the company. Amalgamated Bank raised its holdings in Oscar Health by 10.6% in the 3rd quarter. Amalgamated Bank now owns 15,762 shares of the company’s stock valued at $88,000 after acquiring an additional 1,516 shares in the last quarter. Summit Trail Advisors LLC raised its position in Oscar Health by 9.5% in the 1st quarter. Summit Trail Advisors LLC now owns 19,755 shares of the company’s stock valued at $294,000 after purchasing an additional 1,715 shares during the last quarter. New York State Common Retirement Fund raised its position in Oscar Health by 3.8% in the 4th quarter. New York State Common Retirement Fund now owns 64,856 shares of the company’s stock valued at $593,000 after purchasing an additional 2,394 shares during the last quarter. ProShare Advisors LLC increased its stake in shares of Oscar Health by 10.9% in the 1st quarter. ProShare Advisors LLC now owns 28,950 shares of the company’s stock valued at $430,000 after buying an additional 2,842 shares during the period. Finally, Oppenheimer & Co. Inc. increased its stake in shares of Oscar Health by 20.8% in the 1st quarter. Oppenheimer & Co. Inc. now owns 19,450 shares of the company’s stock valued at $289,000 after buying an additional 3,350 shares during the period. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.